Vascular experts are wading through a constant stream of data to continue refining the best approaches to avoid dangerous thrombosis events in people sick with the novel coronavirus.
Researchers continue to hone in on how best to prevent blood clots, which cause strokes and heart attacks, without unintended side effects.
In an effort to find better treatment solutions for the deadly condition, one researcher is making blood clots her focus.
A new study finds patients were taking too many antithrombotics for no reason, leading to a significant increase in bleeding events.
A 25-year journey leads to the first calf vein thrombosis patients treated with a selectin inhibitor strategy.